EQ NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Equillium Inc · Healthcare · Biotechnology

Latest close 2.20 USD
-11.6% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 2.6% above the Trend Line and sits at 56.5% of its 52-week range. The latest completed week returned -11.6%, after a -24.4% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is mixed with 38/100 conviction, while the latest news-sentiment score is 57/100. Near-term considerations: volume confirmation is below normal; earnings are due in 11d.

Setup score 46 out of 100
Latest Close 2.20 USD 31 Jul 2026
1W Return -11.6% latest completed week
4W Return -24.4% short-term follow-through
12W Return 4.3% quarterly tape
Trend Breadth 90.4% 47 of 52 weeks active
Volume Ratio 0.7x vs 13-week average
What is working
  • The trend backdrop is active with a 21-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 2 reversal markers appear in the recent smart-money tape.
  • The share remains more than 20% below its 52-week high.
  • The latest week was a sharp negative move.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 2.6% above the Trend Line and sits at 56.5% of its 52-week range. The latest completed week returned -11.6%, after a -24.4% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.8512-week average 0.90

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.85Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -24.4% over four weeks, 4.3% over 12 weeks, and 209.9% over one year. The current trend has remained active for 21 consecutive weeks.

Performance by holding period

1W-11.6%
4W-24.4%
12W4.3%
26W54.9%
52W209.9%
Active trend streak21 weeks
Active weeks in one year47
Trend breadth90.4%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.07Latest activity-pressure read.
Pressure change-93.9%Four-week change in activity pressure.
Leadership13.69Latest relative-leadership reading.
RS change-76.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 64% Model confidence 61%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength81/100Blend of value, momentum, and quality. Underlying universe rank 20; rank 1 is best.
Value65/100Relative valuation strength. Underlying universe rank 36; rank 1 is best.
Quality64/100Profitability and accounting quality. Underlying universe rank 37; rank 1 is best.
Momentum65/100Medium-term price momentum. Underlying universe rank 36; rank 1 is best.
Growth65/100Revenue and earnings growth. Underlying universe rank 36; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
-
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-19.5%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-
Gross profit retained from each unit of revenue.
Operating margin
-
Operating profit retained from revenue.
Free-cash-flow margin
-
Free cash flow generated from revenue.
Return on invested capital
-
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
1/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-0.4%
Net share repurchases relative to market value.
Shareholder yield
-0.4%
Dividend yield plus net buyback yield.
Net debt / EBITDA
3.2x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningMixed

EQ shows mixed options pressure with a 38/100 conviction score, put-call volume ratio of n/a, expected move of 51.9%, and Sharemaestro trend signal active.

Conviction38/100
Expected move51.9%
Put/call volume
Pressure-12
Speculation0
Volatility96
Trend agreement91
Open options detail
Insider activity8 / 12

8 acquisitions and 12 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment57/100

Weighted news tone is neutral across 53 relevant articles.

17 positive · 32 neutral · 4 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings11dNext report is scheduled for 13 Aug 2026; event risk rises as the date approaches.
Options expected move51.9%Nearest-chain priced movement where available.
52-week drawdown-37.9%Distance below the 52-week high.
13-week volatility9.6%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2610 weeks finished lower.
Best week+39.5%Week of 13 Mar.
Worst week-13.8%Week of 20 Mar.
Latest week-11.6%Week of 31 Jul.

Shape of recent returns

Strong gains9
Modest gains5
Flat weeks2
Modest losses3
Sharp losses7
Recent vol9.6%13-week weekly-return volatility.
Base vol24.4%52-week weekly-return volatility.
Up/down split26/23Count of positive and negative weeks in the 52-week window.
Average skew17.7% / -10.3%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20262.20 USD-11.6%2.14 USD1.21 USD0.0713.692.8MOn
24 Jul 20262.49 USD-3.9%2.12 USD1.20 USD0.7131.102.0MOn
17 Jul 20262.59 USD-11.0%2.09 USD1.19 USD1.1736.963.1MOn
10 Jul 20262.91 USD0.0%2.04 USD1.17 USD1.2950.666.5MOn
3 Jul 20262.91 USD-4.6%1.99 USD1.16 USD1.1757.238.5MOn
26 Jun 20263.05 USD0.0%1.92 USD1.15 USD1.1170.641.6MOn
19 Jun 20263.05 USD8.5%1.85 USD1.13 USD1.0767.741.7MOn
12 Jun 20262.81 USD-4.4%1.78 USD1.12 USD0.9463.142.5MOn
5 Jun 20262.94 USD1.4%1.72 USD1.11 USD0.7579.3014.6MOn
29 May 20262.90 USD28.3%1.66 USD1.09 USD0.4873.853.8MOn
22 May 20262.26 USD3.7%1.61 USD1.08 USD0.2843.281.7MOn
15 May 20262.18 USD3.3%1.58 USD1.07 USD0.4242.821.6MOn
8 May 20262.11 USD1.4%1.55 USD1.06 USD0.5340.75850.7KOn
1 May 20262.08 USD-3.7%1.53 USD1.05 USD0.5149.33997.3KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.